Thalassaemia: ki dolgozik rajta

Intézményenként egy kártya. Szűrhetsz célpontra, országra, vagy csak az EU-13 (Horizon Europe felzárkózó) országok intézményeire.

Az EU-13 szűrő, nem rangsor: csak szűkíti a listát.

200+ intézményből 24, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Leállított, visszavont és felfüggesztett vizsgálatok, a szponzor által a regiszterben megadott okkal, szó szerint idézve.

• Leállították

  Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients

  NCT06219239· Institute of Hematology & Blood Diseases Hospital, China· Frissítve: 2026. nov. 4.

  “Suboptimal treatment response”A regiszter szövege, változtatás nélkül. Forrás

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• Combination Therapy With Danazol, Prednisolone, and Thalidomide for Thalidomide-Refractory Transfusion-Dependent β-Thalassemia

  NCT07884773· Khyber Medical University Peshawar· Forrás

• A phase 3B, open-label, single-arm, rollover study to evaluate long-term safety of Luspatercept in subjects who have participated in other Luspatercept (ACE-536) clinical trials.

  2022-502498-40-00· Celgene Corp.· Forrás

• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  NCT06609226· Novo Nordisk A/S· Forrás

• A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

  NCT05664737· Bristol-Myers Squibb· Forrás

• Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias

  NCT00061568· National Heart, Lung, and Blood Institute (NHLBI)· Forrás

• A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

  NCT05891249· Bristol-Myers Squibb· Forrás

• Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure

  NCT02105766· National Heart, Lung, and Blood Institute (NHLBI)· Forrás

• Gene Therapy for Patients With Transfusion-Dependent β-Thalassemia

  NCT07721480· Prince of Wales Hospital, Shatin, Hong Kong· Forrás

• Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

  NCT04143724· Celgene· Forrás

• A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body

  NCT06421636· Regeneron Pharmaceuticals· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 1
• CRISPR-Cas Systems 18
• Gene Expression Profiling 3
• Whole Genome Sequencing 3
• Exome Sequencing 12
• Proteomics 7
• Metabolomics 3
• Mass Spectrometry 1
• Flow Cytometry 1
• Immunohistochemistry 1
• Magnetic Resonance Imaging 30
• Machine Learning 11
• Deep Learning 2
• Cohort Studies 17

• Machine learning for thalassemia detection: a critical review of diagnostic pathways and emerging technologies.

  Prog Biomed Eng (Bristol), 2026. aug.

• Machine learning-assisted colorimetric sensor array for identification and quantitative analysis of iron chelators.

  Biosens Bioelectron, 2026. aug.

• Diagnostic performance of discriminant formulas and machine learning models for detecting β-thalassemia trait in Bangladesh.

  PLoS One, 2026. jún.

• Diagnosis and classification of thalassemia disease using machine learning: Comparative analysis of traditional models and a novel hybrid approach.

  Technol Health Care, 2026. jún.

• Machine learning in the prediction of liver iron concentration and iron chelation therapy adjustment.

  Hematology, 2026. ápr.

• A dual-modal machine learning framework integrating red blood indices and smartphone-captured microscopic images for β-thalassemia screening.

  BMC Med Inform Decis Mak, 2026. márc.

• Comparison of the diagnostic performance of machine learning algorithms for differentiating iron deficiency anemia and thalassemia.

  Ann Hematol, 2026. márc.

• Machine learning and AI-Assisted red blood cell morphology analysis for effective thalassemia screening.

  Ann Hematol, 2026. febr.

• Sustainable and interpretable heart disease prediction: a clinical decision support approach for biomedical healthcare applications.

  Sci Rep, 2026. febr.

• Explainable AI framework for improved Thalassemia mental health classification and feature selection.

  PLoS One, 2026. jan.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.